Beam Therapeutics
BEAM
Reported
Tuesday, February 25
Q4 2024 Earnings
| (USD) | Expected | Reported | Surprise $ | Surprise % |
|---|---|---|---|---|
| EPS | -1.28 | -1.09 | 0.19 | 14.84% |
| Revenue | 15.1M | 30.1M | 14.9M | 98.86% |
WhatIF - Earnings
EPS Beat Expectations by $0.19
Beam Therapeutics (BEAM:NASDAQ) has never beaten EPS by this much before
There’s a first time for everything